Statistics for "Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial"

Record

Title: Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
Type: Journal Article
Publ. year: 2015
Author/s: Bielack, Stefan S; Smeland, Sigbjørn; Whelan, Jeremy S; Marina, Neyssa et al.
Department/s: Tumor microenvironment
In LUP since: 2016-04-01

Downloads

Total	This Year	This Month
84	4	0

Downloads per country
United States of America	54 (64%)
France	10 (12%)
Russian Federation	4 (5%)
Romania	2 (2%)
Hong Kong (China)	2 (2%)
Sweden	2 (2%)
China	1 (1%)
Germany	1 (1%)
Saudi Arabia	1 (1%)
India	1 (1%)
Ukraine	1 (1%)
Italy	1 (1%)
United Kingdom of Great Britain and Northern Ireland	1 (1%)
Netherlands (Kingdom of the)	1 (1%)
Singapore	1 (1%)
New Zealand	1 (1%)